System-Biotech: COVID-19 Severity Prediction Test

2021: Sistema-Biotech began to supply tests to medical institutions to predict the severity of the COVID-19 flow

On August 2, 2021, AFK Sistema announced that Sistema-Biotech, a biotechnology company in the group, began to supply the first genetic test in Russia to Moscow clinics, which allows assessing the risk of COVID-19.

According to Vedomosti, a representative of the Moscow Department of Health, a project is being implemented "Conducting comparative tests of technologies for studying the relationship of genetic factors of the human body and the severity of the disease with a new coronavirus infection COVID-19, correlating clinical indicators and strains of the virus." According to him, GKB No. 15 named after O. M. Filatov, GKB No. 40 in Kommunarka, Research Institute of Ambulance named after Sklifosovsky and others will take part in the experiment. The question of the practical application of tests will be decided on the basis of the results of these and other studies, added in Depzdrav.

Sistema-Biotech has begun supplying tests to medical institutions to predict the severity of the COVID-19 flow

The new tests will allow doctors to accurately assess the likelihood of developing dangerous complications or deaths at COVID-19 and to select personalized treatment for patients with coronavirus, which will reduce the burden on the intensive care units of hospitals and the mortality rate among infected

Earlier, Sistema-Biotech completed a large-scale genetic study among Russians in order to assess possible complications and choose the most effective therapy to minimize the risks of disability or death. The study, which was conducted by studying genetic material isolated from the blood of sick patients, used more than 500 samples obtained from patients from intensive care units, as well as long-term contact with patients since the beginning of 2020.

As a result, a number of genetic markers encoding the most common clinical manifestations of coronavirus infection were identified: 7 markers reliably associated with the risk of the disease and its severe course, as well as two protective (protective) markers both in relation to the risk of the occurrence and severity of the coronavirus infection. In particular, certain genes show the probability of high temperature, reduced saturation and cytokine storm. This means that carriers of protective genes will carry the disease more easily, have fewer complications and recover faster.^[1]

Notes